Skip to Content
 
 
 
 

NRG-BR004: A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer (Location: Aberdeen)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Jason Jones, MD

Clinical Trial Categories

  • Breast Cancer
Contact
Gynecology Breast Coordinators at 605-322-7536
or gyn.breastresearch@avera.org

Location

  • Avera Cancer Institute at Aberdeen
    310 S Penn St. Suite 105
    Aberdeen, SD 57401
    Main: 605-622-8700
    Fax: 605-622-5056

Moving Health Forward

Avera is a health ministry rooted in the Gospel. Our mission is to make a positive impact in the lives and health of persons and communities by providing quality services guided by Christian values.

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.